Published in Antimicrob Agents Chemother on August 24, 2015
Reexamining Chronic Toxoplasma gondii Infection: Surprising Activity for a "Dormant" Parasite. Curr Clin Microbiol Rep (2016) 0.75
Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Des Devel Ther (2017) 0.75
A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016). Front Microbiol (2017) 0.75
Translational Control in the Latency of Apicomplexan Parasites. Trends Parasitol (2017) 0.75
Dose translation from animal to human studies revisited. FASEB J (2007) 15.67
Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Methods Cell Biol (1994) 5.50
Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature (2012) 3.54
Dissecting the loci of low-level quinine resistance in malaria parasites. Mol Microbiol (2004) 3.30
Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science (2011) 3.29
Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev (2005) 2.43
The scanning mechanism of eukaryotic translation initiation. Annu Rev Biochem (2014) 2.41
Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism. Adv Nutr (2012) 2.27
The Plasmodium eukaryotic initiation factor-2alpha kinase IK2 controls the latency of sporozoites in the mosquito salivary glands. J Exp Med (2010) 2.08
Plasmodium falciparum: assessment of in vitro growth by [3H]hypoxanthine incorporation. Exp Parasitol (1983) 2.03
The development and biology of bradyzoites of Toxoplasma gondii. Front Biosci (2000) 1.84
Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science (2015) 1.80
PK4, a eukaryotic initiation factor 2α(eIF2α) kinase, is essential for the development of the erythrocytic cycle of Plasmodium. Proc Natl Acad Sci U S A (2012) 1.72
Genetic analysis of tachyzoite to bradyzoite differentiation mutants in Toxoplasma gondii reveals a hierarchy of gene induction. Mol Microbiol (2002) 1.61
Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol Rev (2011) 1.35
Translation regulation by eukaryotic initiation factor-2 kinases in the development of latent cysts in Toxoplasma gondii. J Biol Chem (2008) 1.34
Parasite-specific eIF2 (eukaryotic initiation factor-2) kinase required for stress-induced translation control. Biochem J (2004) 1.31
Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis. Proc Natl Acad Sci U S A (2012) 1.24
Phosphorylation of eukaryotic initiation factor-2{alpha} promotes the extracellular survival of obligate intracellular parasite Toxoplasma gondii. Proc Natl Acad Sci U S A (2010) 1.21
Congenital toxoplasmosis. Am Fam Physician (2003) 1.17
Toxoplasmosis. Handb Clin Neurol (2013) 1.11
Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs (1983) 1.11
Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic. Nat Commun (2015) 1.00
Translational control in Plasmodium and toxoplasma parasites. Eukaryot Cell (2012) 0.93
A Toxoplasma gondii mutant defective in responding to calcium fluxes shows reduced in vivo pathogenicity. Mol Biochem Parasitol (2007) 0.91
A genetic screen to isolate Toxoplasma gondii host-cell egress mutants. J Vis Exp (2012) 0.88
Relationship of guanabenz concentrations in brain and plasma to antihypertensive effect in the spontaneously hypertensive rat. J Pharmacol Exp Ther (1980) 0.86
Translation control is critical during acute and chronic stages of toxoplasmosis infection. Expert Rev Anti Infect Ther (2011) 0.85
Inhibitors of eIF2α dephosphorylation slow replication and stabilize latency in Toxoplasma gondii. Antimicrob Agents Chemother (2013) 0.84
Studies on the centrally mediated hypotensive activity of guanabenz. Eur J Pharmacol (1976) 0.83
Why imidazoline receptor modulator in the treatment of hypertension? Ann N Y Acad Sci (1995) 0.80
A quantitative competitive PCR method to determine the parasite load in the brain of Toxoplasma gondii-infected mice. Parasitol Int (2008) 0.80